文献速递腹部介入US

超声融合成像辅助微波消融治疗结直肠癌肝转移:基于肿瘤大小和位置的分层分析研究

Microwave ablation for colorectal liver metastases with ultrasound fusion imaging assistance: a stratified analysis study based on tumor size and location.
PubMed 文献 · Abdom Radiol (NY) · 2024-08-02

按肿瘤大小和血管旁位置分层肝内进展率相似,而被膜下组显著高于非被膜下组(p=0.021)。

要点

  • 超声融合成像辅助微波消融结直肠癌肝转移的局部疗效满意,尤其对非被膜下肿瘤。
  • 被膜下肿瘤肝内进展率显著高于非被膜下肿瘤(p=0.021),阅片和随访时应关注被膜下病灶。
  • 肿瘤大小(≥30 mm vs <30 mm)和血管旁位置对累积肝内进展率无显著影响。

核心结论

  • 超声融合成像辅助微波消融对结直肠癌肝转移表现出满意的局部疗效,尤其对非被膜下肿瘤;被膜下肿瘤的累积肝内进展率显著高于非被膜下肿瘤(p=0.021)。

研究设计与样本

  • 回顾性研究,纳入2020年2月至2023年2月在本院接受超声融合成像辅助微波消融的结直肠癌肝转移患者51例共122个结节;超声融合成像全程用于检测、引导、监测和即刻评估。

诊断标准与关键数值

  • 技术成功和技术有效均在所有结节中获得;中位随访19个月,局部肿瘤进展率为2.5%(3/122);1年和2年累积肝内进展率分别为38.7%和52.1%;按肿瘤大小分层(≥30 mm组n=13,<30 mm组n=38)和血管旁位置分层(血管旁组n=20,非血管旁组n=31)的累积肝内进展率相似;被膜下组(n=36)累积肝内进展率显著高于非被膜下组(n=15),p=0.021。

临床应用与阅片要点

  • 超声融合成像可用于结直肠癌肝转移微波消融的检测、引导、监测和即刻评估;被膜下肿瘤的肝内进展率显著高于非被膜下肿瘤,作者结论认为该技术对非被膜下肿瘤的局部疗效尤其满意。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To investigate the efficacy of ultrasound fusion imaging-assisted microwave ablation (MWA) for patients with colorectal liver metastases (CRLM) based on stratified analysis of tumor size and location.

METHODS: Patients with CRLM who underwent ultrasound fusion imaging-assisted MWA in our hospital between February 2020 and February 2023 were enrolled into this retrospective study. Ultrasound fusion imaging was used for detection, guidance, monitoring and immediate evaluation throughout the MWA procedures. Technical success, technique efficacy, local tumor progression (LTP), intrahepatic progression and overall survival (OS) were recorded and analyzed. The subgroup analysis of intrahepatic progression of MWA for CRLM was performed according to tumor size and location.

RESULTS: A total of 51 patients with 122 nodules were enrolled. Both technical success and technique efficacy were acquired in all nodules. In a median follow-up period of 19 months, 2.5% of the nodules (3/122) were observed LTP. The 1-year and 2-year cumulative intrahepatic progression rates were 38.7% and 52.1% respectively. Patients were divided into subgroups according to tumor size (≥ 30 mm, n = 13; < 30 mm, n = 38) and tumor location (perivascular, n = 20; non-perivascular, n = 31 and subcapsular, n = 36; non-subcapsular, n = 15). The cumulative intrahepatic progression rates were similar between the subgroups regarding tumor size and perivascular location, while significantly higher in the subcapsular group than in the non-subcapsular group (p = 0.021).

CONCLUSION: Ultrasound fusion imaging-assisted MWA exhibited satisfactory local efficacy for CRLM, especially for non-subcapsular tumors.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Lin J, Liu H, Liang S, et al. Microwave ablation for colorectal liver metastases with ultrasound fusion imaging assistance: a stratified analysis study based on tumor size and location. Abdom Radiol (NY). 2024. PMID: 39090260. doi:10.1007/s00261-024-04508-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。